[Skip to Content]

Upstate Active Clinical Trials

Study Title:

An Open Label, Randomized, Adaptive, Two-Arm, Multicenter Trial to Evaluate Pharmackinetics and Pharmacodynamics of Two Doses of Oseltamivir (Tamilflu) in the Treatment of Influenza in Immunocompromised Children, Less than 13 Years of Age, with Confirmed Influenza Infection.

What is the purpose of the study? (in Layman's terms, please describe the study)

To investigate the safety and tolerability of twice daily conventional and double dose Tamiflu (oseltamivir) for the treatment of influenza in immunocompromised patients.

Upstate Institutional Review Board (IRB) Number:


Study/Protocol ID:


Study Phase:


Patient Age Group:


Principal Investigator:

Leonard B Weiner

What is involved if I participate?

  • How long is the study?
    35-50 days total
  • Is transportation provided or reimbursed?
  • Is parking provided or reimbursed?
  • What tests and procedures are involved?
    Vital signs, blood work, nasal swabs.

ClinicalTrials.Gov ID:


For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Wendy A Holz
Phone: 315-464-7562
Email: holzw@upstate.edu

Return to Previous Page || Search Again